Induction ChemotherapyChemoradiotherapyAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyChemoradiotherapy, AdjuvantCisplatinChemotherapy, AdjuvantNeoadjuvant TherapyRadiotherapy, AdjuvantTreatment OutcomeRemission InductionFluorouracilCarcinoma, Squamous CellDisease-Free SurvivalHead and Neck NeoplasmsNeoplasm StagingSurvival AnalysisSurvival RateRadiotherapy DosageEsophageal NeoplasmsAntineoplastic AgentsLung NeoplasmsRadiotherapyCarboplatinEtoposidePrognosisTaxoidsCyclophosphamidePaclitaxelDrug Administration ScheduleRectal NeoplasmsDoxorubicinHypopharyngeal NeoplasmsDeoxycytidineNasopharyngeal NeoplasmsNeoplasm Recurrence, LocalCytarabineCarcinoma, Non-Small-Cell LungEsophagectomyDose FractionationKaplan-Meier EstimateAntimetabolites, AntineoplasticLeukemia, Myeloid, AcuteAdenocarcinomaIfosfamideDaunorubicinOrgan Sparing TreatmentsLaryngectomyVincristineLaryngeal NeoplasmsFollow-Up StudiesMucositisVinblastineRetrospective StudiesTransplantation, AutologousOropharyngeal NeoplasmsSalvage TherapyEnzyme InductionMethotrexateTime FactorsOrganoplatinum CompoundsPrecursor Cell Lymphoblastic Leukemia-LymphomaIdarubicinRadiotherapy, ConformalLeucovorinRadiotherapy, High-EnergyProspective StudiesHydroxyureaNeutropeniaBleomycinFeasibility StudiesLeukemia, MyeloidMelphalanPreoperative CareLymphatic MetastasisNeoplasm MetastasisBreast NeoplasmsLeukopeniaRadiation-Sensitizing AgentsPositron-Emission TomographyCranial IrradiationGranulocyte Colony-Stimulating FactorPneumonectomyNeoplasm, ResidualLarynxFluorodeoxyglucose F18Randomized Controlled Trials as TopicRecurrenceDose-Response Relationship, DrugCamptothecinHematopoietic Stem Cell TransplantationNeoplasms, Squamous CellCarcinomaClinical Trials as TopicDrug Resistance, NeoplasmRadiotherapy, Intensity-ModulatedTesticular NeoplasmsClinical Trials, Phase II as TopicRadiation InjuriesAsparaginase